Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Therapy-related myeloid leukemia

M J Thirman¹, R A Larson

¹Section of Hematology/Oncology, Pritzker School of Medicine, University of Chicago, Illinois, USA.

Hematology/Oncology Clinics of North America

|April 1, 1996

Summary

Cancer therapy can lead to secondary leukemia, a serious complication. This article details distinct subtypes, including therapy-related myeloid leukemia and those linked to specific genetic alterations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia·2020

Same author

Treatment of horizontal silage bunker runoff using biochar amended vegetative filter strips.

Journal of environmental management·2019

Same author

Nitrate sorption to biochar following chemical oxidation.

The Science of the total environment·2019

Same author

Constraining the Spatial Extent of Marine Oil Snow Sedimentation and Flocculent Accumulation Following the Deepwater Horizon Event Using an Excess <sup>210</sup>Pb Flux Approach.

Environmental science & technology·2017

Same author

The impact of biogas and fuelwood use on institutional kitchen air quality in Kampala, Uganda.

Indoor air·2017

Same author

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.

Leukemia·2016

Area of Science:

Oncology
Hematology
Cancer Therapeutics

Background:

Cancer treatments, while life-saving, carry the risk of secondary malignancies.
Therapy-related leukemia is a significant concern, necessitating detailed classification.

Purpose of the Study:

To delineate the distinct subsets of therapy-related leukemia.
To provide a comprehensive overview of current knowledge on these secondary leukemias.

Main Methods:

Literature review and synthesis of existing research on therapy-related leukemia.
Classification based on distinct clinical and etiological features.

Main Results:

Identified several key subsets of therapy-related leukemia.
Detailed discussion includes classic therapy-related myeloid leukemia.
Specific subtypes linked to topoisomerase II inhibitors and genetic rearrangements (21q22, inv(16), t(15;17)) are highlighted.

Conclusions:

Understanding these distinct leukemia subsets is crucial for risk assessment and management.
Further research into the mechanisms and prevention of therapy-related leukemia is warranted.

Related Experiment Videos